213 related articles for article (PubMed ID: 20587901)
1. The role of intensity-modulated radiotherapy in head and neck cancer.
Bhide SA; Kazi R; Newbold K; Harrington KJ; Nutting CM
Indian J Cancer; 2010; 47(3):267-73. PubMed ID: 20587901
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
3. DARS: a phase III randomised multicentre study of dysphagia- optimised intensity- modulated radiotherapy (Do-IMRT) versus standard intensity- modulated radiotherapy (S-IMRT) in head and neck cancer.
Petkar I; Rooney K; Roe JW; Patterson JM; Bernstein D; Tyler JM; Emson MA; Morden JP; Mertens K; Miles E; Beasley M; Roques T; Bhide SA; Newbold KL; Harrington KJ; Hall E; Nutting CM
BMC Cancer; 2016 Oct; 16(1):770. PubMed ID: 27716125
[TBL] [Abstract][Full Text] [Related]
4. Comparison of methods to reduce dose to swallowing-related structures in head and neck cancer.
Caudell JJ; Burnett OL; Schaner PE; Bonner JA; Duan J
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):462-7. PubMed ID: 19577862
[TBL] [Abstract][Full Text] [Related]
5. Intensity-modulated radiotherapy for head and neck cancer.
Caglar HB; Allen AM
Clin Adv Hematol Oncol; 2007 Jun; 5(6):425-31. PubMed ID: 17679916
[TBL] [Abstract][Full Text] [Related]
6. Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing.
Eisbruch A; Marsh LH; Dawson LA; Bradford CR; Teknos TN; Chepeha DB; Worden FP; Urba S; Lin A; Schipper MJ; Wolf GT
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):28-42. PubMed ID: 15093896
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of image-guided radiotherapy for laryngeal sparing in head and neck cancer.
Nguyen NP; Ceizyk M; Vos P; Vinh-Hung V; Davis R; Desai A; Abraham D; Krafft SP; Jang S; Watchman CJ; Ewell L; Hamilton R; Smith-Raymond L
Oral Oncol; 2010 Apr; 46(4):283-6. PubMed ID: 20188620
[TBL] [Abstract][Full Text] [Related]
8. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results.
Chao KS; Deasy JO; Markman J; Haynie J; Perez CA; Purdy JA; Low DA
Int J Radiat Oncol Biol Phys; 2001 Mar; 49(4):907-16. PubMed ID: 11240231
[TBL] [Abstract][Full Text] [Related]
9. Clinical evaluation of intensity-modulated radiotherapy for head and neck cancers.
Bhide SA; Newbold KL; Harrington KJ; Nutting CM
Br J Radiol; 2012 May; 85(1013):487-94. PubMed ID: 22556403
[TBL] [Abstract][Full Text] [Related]
10. The potential for sparing of parotids and escalation of biologically effective dose with intensity-modulated radiation treatments of head and neck cancers: a treatment design study.
Wu Q; Manning M; Schmidt-Ullrich R; Mohan R
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):195-205. PubMed ID: 10656393
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of salivary gland function after treatment of head-and-neck tumors with intensity-modulated radiotherapy by quantitative pertechnetate scintigraphy.
Münter MW; Karger CP; Hoffner SG; Hof H; Thilmann C; Rudat V; Nill S; Wannenmacher M; Debus J
Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):175-84. PubMed ID: 14697436
[TBL] [Abstract][Full Text] [Related]
12. A phase II study to assess the efficacy of amifostine for submandibular/sublingual salivary sparing during the treatment of head and neck cancer with intensity modulated radiation therapy for parotid salivary sparing.
Rosenthal DI; Chambers MS; Weber RS; Eisbruch A
Semin Oncol; 2004 Dec; 31(6 Suppl 18):25-8. PubMed ID: 15726519
[TBL] [Abstract][Full Text] [Related]
13. Intensity-modulated radiotherapy or volumetric-modulated arc therapy in patients with head and neck cancer: Focus on salivary glands dosimetry.
Vallard A; Guy JB; Mengue Ndong S; Vial N; Rivoirard R; Auberdiac P; Méry B; Langrand-Escure J; Espenel S; Moncharmont C; Ben Mrad M; Diao P; Goyet D; Magné N
Head Neck; 2016 Jul; 38(7):1028-34. PubMed ID: 26855006
[TBL] [Abstract][Full Text] [Related]
14. Protection of salivary function by intensity-modulated radiation therapy in patients with head and neck cancer.
Chao KS
Semin Radiat Oncol; 2002 Jan; 12(1 Suppl 1):20-5. PubMed ID: 11917280
[TBL] [Abstract][Full Text] [Related]
15. Intensity-modulated radiation therapy in head-and-neck carcinomas: Potential beyond sparing the parotid glands.
Sharma A; Bahl A
J Cancer Res Ther; 2020; 16(3):425-433. PubMed ID: 32719246
[TBL] [Abstract][Full Text] [Related]
16. Feasibility of Tomotherapy to spare the cochlea from excessive radiation in head and neck cancer.
Nguyen NP; Smith-Raymond L; Vinh-Hung V; Sloan D; Davis R; Vos P; Abraham D; Stevie M; Krafft SP; Ly BH; Ries T; Karlsson U; Ceizyk M
Oral Oncol; 2011 May; 47(5):414-9. PubMed ID: 21474364
[TBL] [Abstract][Full Text] [Related]
17. Target coverage for head and neck cancers treated with IMRT: review of clinical experiences.
Garden AS; Morrison WH; Rosenthal DI; Chao KS; Ang KK
Semin Radiat Oncol; 2004 Apr; 14(2):103-9. PubMed ID: 15095256
[TBL] [Abstract][Full Text] [Related]
18. Intensity-modulated radiation therapy in head and neck cancers: The Mallinckrodt experience.
Chao KS; Low DA; Perez CA; Purdy JA
Int J Cancer; 2000 Apr; 90(2):92-103. PubMed ID: 10814959
[TBL] [Abstract][Full Text] [Related]
19. Potential advantages of volumetric arc therapy in head and neck cancer.
Gomez-Millan Barrachina J; Jerez Sainz I; Perez Rozos A; Ramirez Ros JC; Toledo Serrano MD; Lupiañez Perez Y; Medina Carmona JA
Head Neck; 2015 Jun; 37(6):909-14. PubMed ID: 24623665
[TBL] [Abstract][Full Text] [Related]
20. Correlating planned radiation dose to the cochlea with primary site and tumor stage in patients with head and neck cancer treated with intensity-modulated radiation therapy.
Zhang J; Qureshi MM; Kovalchuk N; Truong MT
Med Dosim; 2014; 39(1):88-92. PubMed ID: 24485054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
